A Systems Biology Perspective on Obesity and Type 2 Diabetes

Molecular System Bioenergetics: Energy for Life

Volumn , Issue , 2007, Pages 571-592

  Ciapaite, Jolita ^a,b   Bakker, Stephan J L ^c   Heine, Robert J ^d   Krab, Klaas ^b   Westerhoff, Hans V ^b,e  

^a VYTAUTAS MAGNUS UNIVERSITY   (Lithuania)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Applied molecular system bioenergetics; Fatty acid induced cell dysfunction; Fatty acid induced insulin resistance; Glucose homeostasis; Metabolic control analysis; Obesity; Type 2 diabetes

Indexed keywords

EID: 84889346185     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527621095.ch18     Document Type: Chapter

References (119)

1. Wild, S., Roglic, G., Green, A., Sicree, R., King H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.
2. Ray, J.A., Valentine, W.J., Secnik, K., Oglesby, A.K., Cordony, A., Gordois, A., Davey, P., Palmer, A.J. (2005) Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr. Med. Res. Opin. 21, 1617-1629.
3. Zhou, H., Isaman, D.J., Messinger, S., Brown, M.B., Klein, R., Brandle, M., Herman, W.H. (2005) A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care 28, 2856-2863.
4. Malecki, M.T. (2005) Genetics of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 68, S10-S21.
5. Shepherd, P.R., Kahn, B.B. (1999) Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341, 248-257.
6. Maechler, P. (2002) Mitochondria as the conductor of metabolic signals for insulin exocytosis in pancreatic betacells. Cell. Mol. Life Sci. 59, 1803-1818.
7. Saltiel, A.R., Kahn, C.R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
8. Dohm, G.L. (2002) Invited review: Regulation of skeletal muscle GLUT4 expression by exercise. J. Appl. Physiol. 93, 782-787.
9. Mokdad, A.H., Ford, E.S., Bowman, B.A., Dietz, W.H., Vinicor, F., Bales, V.S., Marks, J.S. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 289, 76-79.
10. Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., Jensen, M.D. (2004) Splanchnic lipolysis in human obesity. J. Clin. Invest. 113, 1582-1588.
11. Sopasakis, V.R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P.A., Smith, U. (2004) High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes. Res. 12, 454-460.
12. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
13. Hirsch, J., Batchelor, B. (1976) Adipose tissue cellularity in human obesity. Clin. Endocrinol. Metab. 5, 299-311.
14. Salans, L.B., Knittle, J.L., Hirsch, J. (1968) The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J. Clin. Invest. 47, 153-165.
15. DiGirolamo, M., Howe, M.D., Esposito, J., Thurman, L., Owens, J.L. (1974) Metabolic patterns and insulin responsiveness of enlarging fat cells. J. Lipid Res. 15, 332-338.
16. Jensen, M.D., Caruso, M., Heiling, V., Miles, J.M. (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38, 1595-1601.
17. Jensen, M.D., Haymond, M.W., Gerich, J.E., Cryer, P.E., Miles, J.M. (1987) Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J. Clin. Invest. 79, 207-213.
18. Galster, A.D., Clutter, W.E., Cryer, P.E., Collins, J.A., Bier, D.M. (1981) Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid. J. Clin. Invest. 67, 1729-1738.
19. Camastra, S., Manco, M., Mari, A., Baldi, S., Gastaldelli, A., Greco, A.V., Mingrone, G., Ferrannini, E. (2005) beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 54, 2382-2389.
20. Horowitz, J.F., Coppack, S.W., Paramore, D., Cryer, P.E., Zhao, G., Klein, S. (1999) Effect of short-term fasting on lipid kinetics in lean and obese women. Am. J. Physiol. 276, E278-E284.
21. Heiling, V.J., Miles, J.M., Jensen, M.D. (1991) How valid are isotopic measurements of fatty acid oxidation? Am. J. Physiol. 261, E572-E577.
22. Koonen, D.P., Glatz, J.F., Bonen, A., Luiken, J.J. (2005) Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta 1736, 163-180.
23. Boden, G., Lebed, B., Schatz, M., Homko, C., Lemieux, S. (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50, 1612-1617.
24. Koyama, K., Chen, G., Lee, Y., Unger, R.H. (1997) Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. 273, E708-E713.
25. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A.J., Natale, S., Forlani, G., Melchionda, N. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844-1850.
26. Hennes, M.M., Dua, A., Kissebah, A.H. (1997) Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46, 57-62.
27. Boucher, A., Lu, D., Burgess, S.C., Telemaque-Potts, S., Jensen, M.V., Mulder, H., Wang, M.Y., Unger, R.H., et al. (2004) Biochemical mechanism of lipid-induced impairment of glucosestimulated insulin secretion and reversal with a malate analogue. J. Biol. Chem. 279, 27263-27271.
28. Briaud, I., Harmon, J.S., Kelpe, C.L., Segu, V.B., Poitout, V. (2001) Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50, 315-321.
29. Feng, D.D., Luo, Z., Roh, S.G., Hernandez, M., Tawadros, N., Keating, D.J., Chen, C. (2006) Reduction in voltage-gated K{thorn} currents in primary cultured rat pancreatic beta-cells by linoleic acids. Endocrinology 147, 674-682.
30. Griffin, M.E., Marcucci, M.J., Cline, G.W., Bell, K., Barucci, N., Lee, D., Goodyear, L.J., Kraegen, E.W., et al. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48, 1270-1274.
31. Yu, C., Chen, Y., Cline, G.W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J.K., et al. (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236.
32. Powell, D.J., Turban, S., Gray, A., Hajduch, E., Hundal, H.S. (2004) Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 382, 619-629.
33. Chung, S., Brown, J.M., Provo, J.N., Hopkins, R., McIntosh, M.K. (2005) Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J. Biol. Chem. 280, 38445-38456.
34. Chen, X., Iqbal, N., Boden, G. (1999) The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J. Clin. Invest. 103, 365-372.
35. Basu, A., Basu, R., Shah, P., Vella, A., Johnson, C.M., Jensen, M., Nair, K.S., Schwenk, W.F., et al. (2001) Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50, 1351-1362.
36. Kelley, D.E. (2005) Skeletal muscle fat oxidation: timing and flexibility are everything. J. Clin. Invest. 115, 1699-1702.
37. Randle, P.J. (1998) Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14, 263-283.
38. Hajduch, E., Litherland, G.J., Hundal, H.S. (2001) Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett. 492, 199-203.
39. Petersen, K.F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D.L., DiPietro, L., Cline, G.W., et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 1140-1142.
40. Petersen, K.F., Dufour, S., Befroy, D., Garcia, R., Shulman, G.I. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671.
41. Ritov, V.B., Menshikova, E.V., He, J., Ferrell, R.E., Goodpaster, B.H., Kelley, D.E. (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54, 8-14.
42. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124.
43. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273.
44. Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100, 8466-8471.
45. Bandyopadhyay, G.K., Yu, J.G., Ofrecio, J., Olefsky, J.M. (2006) Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285.
46. Chua, B.H., Shrago, E. (1977) Reversible inhibition of adenine nucleotide translocation by long chain acyl-CoA esters in bovine heart mitochondria and inverted submitochondrial particles. J. Biol. Chem. 252, 6711-6714.
47. Rhodes, C.J. (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307, 380-384.
48. Bernard-Kargar, C., Ktorza, A. (2001) Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 50, S30-S35.
49. Soejima, A., Inoue, K., Takai, D., Kaneko, M., Ishihara, H., Oka, Y., Hayashi, J.I. (1996) Mitochondrial DNA is required for regulation of glucosestimulated insulin secretion in a mouse pancreatic beta cell line, MIN6. J. Biol. Chem. 271, 26194-26199.
50. Tsuruzoe, K., Araki, E., Furukawa, N., Shirotani, T., Matsumoto, K., Kaneko, K., Motoshima, H., Yoshizato, K., et al. (1998) Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes 47, 621-631.
51. Feng, D.D., Luo, Z., Roh, S.G., Hernandez, M., Tawadros, N., Keating, D.J., Chen, C. (2006) Reduction in voltage-gated K{thorn} currents in primary cultured rat pancreatic beta-cells by linoleic acids. Endocrinology 147, 674-682.
52. Bratanova-Tochkova, T.K., Cheng, H., Daniel, S., Gunawardana, S., Liu, Y.J., Mulvaney-Musa, J., Schermerhorn, T., Straub, S.G., et al. (2002) Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51, S83-S90.
53. Zhou, Y.P., Grill, V.E. (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93, 870-876.
54. Gremlich, S., Bonny, C., Waeber, G., Thorens, B. (1997) Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 272, 30261-30269.
55. Butler, A.E., Janson, J., Soeller, W.C., Butler, P.C. (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52, 2304-2314.
56. Cnop, M., Hannaert, J.C., Hoorens, A., Eizirik, D.L., Pipeleers, D.G. (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50, 1771-1777.
57. Lupi, R., Dotta, F., Marselli, L., Del Guerra, S., Masini, M., Santangelo, C., Patane, G., Boggi, U., et al. (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51, 1437-1442.
58. Maedler, K., Spinas, G.A., Dyntar, D., Moritz, W., Kaiser, N., Donath, M.Y. (2001) Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50, 69-76.
59. Shimabukuro, M., Zhou, Y.T., Levi, M., Unger, R.H. (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U.S.A. 95, 2498-2502.
60. Maestre, I., Jordan, J., Calvo, S., Reig, J.A., Cena, V., Soria, B., Prentki, M., Roche, E. (2003) Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the b-cell line INS-1. Endocrinology 144, 335-345.
61. Wang, X., Li, H., De Leo, D., Guo, W., Koshkin, V., Fantus, I.G., Giacca, A., Chan, C.B., et al. (2004) Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line MIN6. Diabetes 53, 129-140.
62. Joseph, J.W., Koshkin, V., Saleh, M.C., Sivitz, W.I., Zhang, C.Y., Lowell, B.B., Chan, C.B., Wheeler, M.B. (2004) Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 279, 51049-51056.
63. Schonfeld, P., Wieckowski, M.R., Wojtczak, L. (2000) Long-chain fatty acid-promoted swelling of mitochondria: further evidence for the protonophoric effect of fatty acids in the inner mitochondrial membrane. FEBS Lett. 471, 108-112.
64. Hornberg, J.J., Bruggeman, F.J., Westerhoff, H.V., Lankelma, J. (2006) Cancer: a Systems Biology disease. Biosystems 83, 81-90.
65. Kitano, H., Oda, K., Kimura, T., Matsuoka, Y., Csete, M., Doyle, J., Muramatsu, M. (2004) Metabolic syndrome and robustness tradeoffs. Diabetes 53, S6-S15.
66. Kitano, H. (2002) Computational systems biology. Nature 420, 206-210.
67. Kitano, H. (2002) Systems biology: a brief overview. Science 295, 1662-1664.
68. Westerhoff, H.V., Palsson, B.O. (2004) The evolution of molecular biology into systems biology. Nat. Biotechnol. 22, 1249-1252.
69. Cascante, M., Boros, L.G., Comin-Anduix, B., de Atauri, P., Centelles, J.J., Lee, P.W. (2002) Metabolic control analysis in drug discovery and disease. Nat. Biotechnol. 20, 243-249.
70. Yarmush, M.L., Banta, S. (2003) Metabolic engineering: advances in modeling and intervention in health and disease. Annu. Rev. Biomed. Eng. 5, 349-381.
71. Kacser, H., Burns, J.A. (1973) The control of flux. Symp. Soc. Exp. Biol. 27, 65-104.
72. Heinrich, R., Rapoport, T.A. (1974) A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur. J. Biochem. 42, 89-95.
73. Burns, J.A., Cornish-Bowden, A., Groen, A.K., Heinrich, R., Kacser, H., Porteous, J.W., Rapoport, S.M., Rapoport, T.A., et al. (1985) Control of metabolic systems. Trends Biochem. Sci. 10, 16.
74. Kacser, H., Burns, J.A. (1979) Molecular democracy: who shares the controls? Biochem. Soc. Trans. 7, 1149-1160.
75. Westerhoff, H.V., Chen, Y.D. (1984) How do enzyme activities control metabolite concentrations? An additional theorem in the theory of metabolic control. Eur. J. Biochem. 142, 425-430.
76. Westerhoff, H.V., Kell, D.B. (1987) Matrix method for determining the steps most rate-limiting to metabolic fluxes in biotechnological processes. Biotechnol. Bioeng. 30, 101-107.
77. Reder, C. (1988) Metabolic control theory: a structural approach. J. Theor. Biol. 135, 175-201.
78. Hofmeyr, J.H., Cornish-Bowden, A., Rohwer, J.M. (1993) Taking enzyme kinetics out of control; putting control into regulation. Eur. J. Biochem. 212, 833-837.
79. Fell, D.A. (1992) Metabolic control analysis: a survey of its theoretical and experimental development. Biochem. J. 286, 313-330.
80. Kacser, H., Burns, J.A. (1981) The molecular basis of dominance. Genetics 97, 639-666.
81. Bohnensack, R., Kuster, U., Letko, G. (1982) Rate-controlling steps of oxidative phosphorylation in rat liver mitochondria. A synoptic approach of model and experiment. Biochim. Biophys. Acta. 680, 271-280.
82. Groen, A.K., Wanders, R.J., Westerhoff, H.V., van der Meer, R., Tager, J.M. (1982) Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257, 2754-2757.
83. Duszynski, J., Groen, A.K., Wanders, R.J., Vervoorn, R.C., Tager, J.M. (1982) Quantification of the role of the adenine nucleotide translocator in the control of mitochondrial respiration in isolated rat-liver cells. FEBS Lett. 146, 262-266.
84. Tager, J.M., Groen, A.K., Wanders, R.J., Duszynski, J.,Westerhoff, H.V., Vervoorn, R.C. (1983) Control of mitochondrial respiration. Biochem. Soc. Trans. 11, 40-43.
85. Gellerich, F.N., Bohnensack, R., Kunz, W. (1983) Control of mitochondrial respiration. The contribution of the adenine nucleotide translocator depends on the ATP-and ADP-consuming enzymes. Biochim. Biophys. Acta 722, 381-391.
86. Borutaite, V., Mildaziene, V., Brown, G.C., Brand, M.D. (1995) Control and kinetic analysis of ischemia-damaged heart mitochondria: which parts of the oxidative phosphorylation system are affected by ischemia? Biochim. Biophys. Acta 1272, 154-158.
87. Westerhoff, H.V., Plomp, P.J., Groen, A.K., Wanders, R.J., Bode, J.A., van Dam, K. (1987) On the origin of the limited control of mitochondrial respiration by the adenine nucleotide translocator. Arch. Biochem. Biophys. 257, 154-169.
88. Hafner, R.P., Brown, G.C., Brand, M.D. (1990) Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and protonmotive force in isolated mitochondria using the ''topdown'' approach of metabolic control theory. Eur. J. Biochem. 188, 313-319.
89. Kesseler, A., Brand, M.D. (1994) Effects of cadmium on the control and internal regulation of oxidative phosphorylation in potato tuber mitochondria. Eur. J. Biochem. 225, 907-922.
90. Wanders, R.J., van Roermund, C.W., Meijer, A.J. (1984) Analysis of the control of citrulline synthesis in isolated rat-liver mitochondria. Eur. J. Biochem. 142, 247-254.
91. Ainscow, E.K., Brand, M.D. (1999) Internal regulation of ATP turnover, glycolysis and oxidative phosphorylation in rat hepatocytes. Eur. J. Biochem. 266, 737-749.
92. Chassagnole, C., Fell, D.A., Rais, B., Kudla, B., Mazat, J.P. (2001) Control of the threonine-synthesis pathway in Escherichia coli: a theoretical and experimental approach. Biochem. J. 56, 433-444.
93. Snoep, J.L., van der Weijden, C.C., Andersen, H.W., Westerhoff, H.V., Jensen, P.R. (2002) DNA supercoiling in Escherichia coli is under tight and subtle homeostatic control, involving gene-expression and metabolic regulation of both topoisomerase I and DNA gyrase. Eur. J. Biochem. 269, 1662-1669.
94. Bakker, B.M., Michels, P.A., Opperdoes, F.R., Westerhoff, H.V. (1999) What controls glycolysis in bloodstream form Trypanosoma brucei? J. Biol. Chem. 274, 14551-14559.
95. Jucker, B.M., Barucci, N., Shulman, G.I. (1999) Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle. Am. J. Physiol. 277, E505-E512.
96. Bier, M., Teusink, B., Kholodenko, B.N., Westerhoff, H.V. (1996) Control analysis of glycolytic oscillations. Biophys. Chem. 62, 15-24.
97. Heinrich, R., Rapoport, T.A. (1975) Mathematical analysis of multienzyme systems. II. Steady state and transient control. Biosystems 7, 130-136.
98. Hornberg, J.J., Bruggeman, F.J., Binder, B., Geest, C.R., de Vaate, A.J., Lankelma, J., Heinrich, R., Westerhoff, H.V. (2005) Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. FEBS J. 272, 244-258.
99. Westerhoff, H.V., van Dam, K. (1987) Thermodynamics and control of free-energy transduction, Elsevier, Amsterdam.
100. Fell, D.A., Sauro, H.M. (1985) Metabolic control and its analysis. Additional relationships between elasticities and control coefficients. Eur. J. Biochem. 148, 555-561.
101. Torres, N.V., Mateo, F., Melendez-Hevia, E., Kacser, H. (1986) Kinetics of metabolic pathways. A system in vitro to study the control of flux. Biochem. J. 234, 169-174.
102. Brown, G.C., Hafner, R.P., Brand, M.D. (1990) A ''top-down'' approach to the determination of control coefficients in metabolic control theory. Eur. J. Biochem. 188, 321-325.
103. Schuster, S., Kahn, D., Westerhoff, H.V. (1993) Modular analysis of the control of complex metabolic pathways. Biophys. Chem. 48, 1-17.
104. Ainscow, E.K., Brand, M.D. (1995) Topdown control analysis of systems with more than one common intermediate. Eur. J. Biochem. 231, 579-586.
105. Ainscow, E.K., Brand, M.D. (1998) Control analysis of systems with reaction blocks that ''cross-talk''. Biochim. Biophys. Acta 1366, 284-290.
106. Schuster, S. (1999) Use and limitations of modular metabolic control analysis in medicine and biotechnology. Metab. Eng. 1, 232-242.
107. Brown, G.C. (1994) Control analysis applied to the whole body: control by body organs over plasma concentrations and organ fluxes of substances in the blood. Biochem. J. 297, 115-122.
108. Kesseler, A., Brand, M.D. (1994) Localisation of the sites of action of cadmium on oxidative phosphorylation in potato tuber mitochondria using topdown elasticity analysis. Eur. J. Biochem. 225, 897-906.
109. Dufour, S., Rousse, N., Cnioni, P., Diolez, P. (1996) Top-down control analysis of temperature effect on oxidative phosphorylation. Biochem. J. 314, 743-751.
110. Krab, K., Wagner, M.J., Wagner, A.M., Moler, I.M. (2000) Identification of the site where the electron transfer chain of plant mitochondria is stimulated by electrostatic charge screening. Eur. J. Biochem. 267, 869-876.
111. Mildaziene, V., Nauciene, Z., Baniene, R., Grigiene, J. (2002) Multiple effects of 2,2,5,5-tetrachlorbiphenyl on oxidative phosphorylation in rat liver mitochondria. Toxicol. Sci. 65, 220-227.
112. Giersch, C. (1994) Determining elasticities from multiple measurements of steady-state flux rates and metabolite concentrations: theory. J. Theor. Biol. 169, 89-99.
113. Ainscow, E.K., Brand, M.D. (1999) Topdown control analysis of ATP turnover, glycolysis and oxidative phosphorylation in rat hepatocytes. Eur. J. Biochem. 263, 671-685.
114. Hofmeyr, J.H., Cornish-Bowden, A. (1996) Co-response analysis: a new experimental strategy for metabolic control analysis. J. Theor. Biol. 182, 371-380.
115. Bakker, S.J., Ijzerman, R.G., Teerlink, T., Westerhoff, H.V., Gans, R.O., Heine, R.J. (2000) Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and b-cell failure? Atherosclerosis 148, 17-21.
116. Bakker, S.J., Gans, R.O., ter Maaten, J.C., Teerlink, T., Westerhoff, H.V., Heine, R.J. (2001) The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 155, 283-290.
117. Ciapaite, J., van Eikenhorst, G., Bakker, S.J., Diamant, M., Heine, R.J., Wagner, M.J., Westerhoff, H.V., Krab, K. (2005) Modular kinetic analysis of the adenine nucleotide translocator-mediated effects of palmitoyl-CoA on the oxidative phosphorylation in isolated rat liver mitochondria. Diabetes 54, 944-951.
118. Ciapaite, J., Bakker, S.J., Diamant, M., van Eikenhorst, G., Heine, R.J., Westerhoff, H.V., Krab, K. (2006) Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects. Implications for a mechanism linking obesity and type 2 diabetes. FEBS J. 273, 5288-5302.
119. Ciapaite, J., Bakker, S.J., van Eikenhorst, G., Wagner, M.J., Teerlink, T., Schalkwijk, C.G., Fodor, M., Ouwens, M.D., et al. (2007) Functioning of oxidative phosphorylation in liver mitochondria of high-fat diet fed rats. Biochim. Biophys. Acta 1772, 307-316.